These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28424575)

  • 41. Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF.
    Savarese G; Orsini N; Hage C; Vedin O; Cosentino F; Rosano GMC; Dahlström U; Lund LH
    JACC Heart Fail; 2018 Mar; 6(3):246-256. PubMed ID: 29428439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical features and prognosis of patients with different types of heart failure in relation to coronary artery disease].
    Zhou Y; Mo T; Bao YP; Wang L; Zhong RR; Tian JL
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1142-1147. PubMed ID: 32311877
    [No Abstract]   [Full Text] [Related]  

  • 43. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.
    Freiberg MS; Chang CH; Skanderson M; Patterson OV; DuVall SL; Brandt CA; So-Armah KA; Vasan RS; Oursler KA; Gottdiener J; Gottlieb S; Leaf D; Rodriguez-Barradas M; Tracy RP; Gibert CL; Rimland D; Bedimo RJ; Brown ST; Goetz MB; Warner A; Crothers K; Tindle HA; Alcorn C; Bachmann JM; Justice AC; Butt AA
    JAMA Cardiol; 2017 May; 2(5):536-546. PubMed ID: 28384660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heart Failure with Mid-Range Ejection Fraction - State of the Art.
    Mesquita ET; Barbetta LMDS; Correia ETO
    Arq Bras Cardiol; 2019 Jul; 112(6):784-790. PubMed ID: 31314831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Characteristics, Comorbidities and Prognosis in Patients With Heart Failure With Mid-Range Ejection Fraction.
    Murtaza G; Paul TK; Rahman ZU; Kelvas D; Lavine SJ
    Am J Med Sci; 2020 Jun; 359(6):325-333. PubMed ID: 32354595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heart Failure with Mid-Range Ejection Fraction - a New Category of Heart Failure or Still a Gray Zone.
    Andronic AA; Mihaila S; Cinteza M
    Maedica (Bucur); 2016 Dec; 11(4):320-324. PubMed ID: 28828050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
    Scherbakov N; Bauer M; Sandek A; Szabó T; Töpper A; Jankowska EA; Springer J; von Haehling S; Anker SD; Lainscak M; Engeli S; Düngen HD; Doehner W
    Eur J Heart Fail; 2015 Oct; 17(10):1015-21. PubMed ID: 26198713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction.
    Tsao CW; Lyass A; Enserro D; Larson MG; Ho JE; Kizer JR; Gottdiener JS; Psaty BM; Vasan RS
    JACC Heart Fail; 2018 Aug; 6(8):678-685. PubMed ID: 30007560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variability of Myocardial Strain During Isometric Exercise in Subjects With and Without Heart Failure.
    Blum M; Hashemi D; Motzkus LA; Neye M; Dordevic A; Zieschang V; Zamani SM; Lapinskas T; Runte K; Kelm M; Kühne T; Tahirovic E; Edelmann F; Pieske B; Düngen HD; Kelle S
    Front Cardiovasc Med; 2020; 7():111. PubMed ID: 32714945
    [No Abstract]   [Full Text] [Related]  

  • 50. Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction.
    Obokata M; Nagata Y; Kado Y; Kurabayashi M; Otsuji Y; Takeuchi M
    J Card Fail; 2017 Mar; 23(3):216-220. PubMed ID: 27737768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition).
    Pandey A; Khan H; Newman AB; Lakatta EG; Forman DE; Butler J; Berry JD
    Hypertension; 2017 Feb; 69(2):267-274. PubMed ID: 27993954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.
    Tromp J; Westenbrink BD; Ouwerkerk W; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Lang CC; Ng LL; Zannad F; Zwinderman AH; Hillege HL; van der Meer P; Voors AA
    J Am Coll Cardiol; 2018 Sep; 72(10):1081-1090. PubMed ID: 30165978
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma levels of free fatty acid differ in patients with left ventricular preserved, mid-range, and reduced ejection fraction.
    Zhu N; Jiang W; Wang Y; Wu Y; Chen H; Zhao X
    BMC Cardiovasc Disord; 2018 May; 18(1):104. PubMed ID: 29843618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of left ventricular ejection fraction on heart failure patients with pulmonary hypertension.
    Zafrir B; Carasso S; Goland S; Zilberman L; Klempfner R; Shlomo N; Radzishevsky E; Hasin T; Shotan A; Vazan A; Weinstein JM; Kinany W; Dragu R; Maor E; Grosman-Rimon L; Amir O
    Heart Lung; 2019; 48(6):502-506. PubMed ID: 31174892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A retrospective analysis of clinical characteristics and outcomes of heart failure patients with different left ventricular ejection fractions].
    Zhou HB; An DQ; Zhan Q; Liu ZH; Hua JH; Lai WY; Huang YL; Zeng QC; Xu DL
    Zhonghua Nei Ke Za Zhi; 2017 Apr; 56(4):253-257. PubMed ID: 28355716
    [No Abstract]   [Full Text] [Related]  

  • 57. Longitudinal evaluation of ventricular ejection fraction and NT-proBNP across heart failure subgroups.
    Martinsson A; Oest P; Wiborg MB; Reitan Ö; Smith JG
    Scand Cardiovasc J; 2018 Aug; 52(4):205-210. PubMed ID: 29656687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmaceutical Treatment for Heart Failure.
    Lin X; Fang L
    Adv Exp Med Biol; 2020; 1177():269-295. PubMed ID: 32246448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers.
    Borovac JA; D'Amario D; Bozic J; Glavas D
    World J Cardiol; 2020 Aug; 12(8):373-408. PubMed ID: 32879702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Device Autonomic Regulation Therapy in Patients with Heart Failure with Reduced Ejection Fraction.
    N Williford N; Statz G; L Mann D; Olshansky B
    J Atr Fibrillation; 2020; 13(1):2409. PubMed ID: 33024509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.